Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Introduction: Severe infections were not rare in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) patients treated with rituximab. The current study aimed to evaluate severe infections in AAV patients received rituximab administration in a single Chinese center. Methods: Twenty...
Saved in:
Main Authors: | Zhi-Ying Li (Author), Min Chen (Author), Ming-Hui Zhao (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
by: Moog P, et al.
Published: (2015) -
Treatment of severe perinuclear antineutrophil cytoplasmic antibody-associated vasculitis with efgartigimod
by: Afsoon Ghafari-Saravi, BS, et al.
Published: (2024) -
Health-related quality of life after Rituximab treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis
by: Iva Parvova, et al.
Published: (2024) -
Antineutrophil cytoplasmic antibodies
by: G.D. Sebastiani
Published: (2011) -
Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives
by: Zdenka Hruskova, et al.
Published: (2020)